CLSN Celsion Corporation Stock Quote

CLSN [NASD]

Index	-	P/E	-	EPS (ttm)	-3.91	Insider Own	0.40%	Shs Outstand	5.77M	Perf Week	-7.81%
Market Cap	16.59M	Forward P/E	-	EPS next Y	-4.25	Insider Trans	64.25%	Shs Float	5.73M	Perf Month	-24.12%
Income	-20.80M	PEG	-	EPS next Q	-0.86	Inst Own	10.00%	Short Float	3.11%	Perf Quarter	-56.32%
Sales	0.50M	P/S	33.18	EPS this Y	62.00%	Inst Trans	0.86%	Short Ratio	0.53	Perf Half Y	-79.02%
Book/sh	8.02	P/B	0.29	EPS next Y	-3.60%	ROA	-34.00%	Target Price	32.67	Perf Year	-85.95%
Cash/sh	5.87	P/C	0.40	EPS next 5Y	-	ROE	-45.30%	52W Range	2.30 - 23.25	Perf YTD	-70.86%
Dividend	-	P/FCF	-	EPS past 5Y	53.60%	ROI	-35.40%	52W High	-89.85%	Beta	2.29
Dividend %	-	Quick Ratio	6.60	Sales past 5Y	0.00%	Gross Margin	-	52W Low	2.61%	ATR	0.25
Employees	29	Current Ratio	6.60	Sales Q/Q	0.00%	Oper. Margin	-	RSI (14)	30.33	Volatility	8.18% 8.42%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-41.00%	Profit Margin	-	Rel Volume	0.08	Prev Close	2.36
Shortable	Yes	LT Debt/Eq	0.13	Earnings	May 16 BMO	Payout	-	Avg Volume	333.75K	Price	2.36
Recom	2.30	SMA20	-16.27%	SMA50	-39.53%	SMA200	-74.55%	Volume	27,723	Change	0.00%

Jul-16-20

Downgrade

Oppenheimer

Outperform → Perform

Jul-14-20

Downgrade

Dawson James

Buy → Neutral

Oct-04-17

Upgrade

Maxim Group

Hold → Buy

Apr-10-17

Resumed

Rodman & Renshaw

Buy

$1.50

Nov-10-16

Downgrade

Maxim Group

Buy → Hold

Jul-12-16

Resumed

H.C. Wainwright

Buy

Jan-19-16

Reiterated

Maxim Group

Buy

$12 → $9

Jul-15-15

Initiated

Maxim Group

Buy

$12

Jan-10-14

Resumed

HC Wainwright

Buy

$5 → $8

Aug-16-12

Reiterated

Griffin Securities

Buy

$10 → $18

Feb-16-12

Initiated

Brean Murray

Buy

Oct-26-11

Initiated

Rodman & Renshaw

Mkt Outperform

Nov-11-09

Initiated

Needham

Buy

May-16-22 08:00AM	Celsion Corporation Reports First Quarter 2022 Financial Results and Provides Business Update GlobeNewswire
May-10-22 08:30AM	Celsion Corporation Highlights Pipeline Progress in Its Lead Development Candidates GlobeNewswire
May-09-22 08:30AM	Celsion Corporation to Hold First Quarter 2022 Financial Results and Business Update Conference Call on Monday, May 16, 2022 GlobeNewswire -8.60%
Apr-21-22 03:24PM	Celsion's Formulated DNA Plasmid COVID-19 Vaccine Candidate Shows Activity Against Two Strains Benzinga
11:30AM	Celsion Corporation Highlighted its PLACCINE Vaccine Platform Technology During Oral Presentation at the World Vaccine Congress GlobeNewswire
Apr-14-22 08:30AM	Celsion and Medidata Present Findings on Use of Synthetic Control Arm to Estimate Treatment Effect in Ovarian Cancer Trial at 2022 AACR Annual Meeting GlobeNewswire
Apr-12-22 08:30AM	Celsion Corporation to Highlight its PLACCINE Platform Technology During Oral Presentation at the World Vaccine Congress GlobeNewswire
Apr-08-22 04:30PM	Celsion Corporation Announces Closing of $7.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules GlobeNewswire -11.21%
Apr-06-22 08:30AM	CELSION CORPORATION ANNOUNCES $7.0 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES GlobeNewswire -16.72%
08:30AM	Celsion and Medidata to Present Findings on Use of Synthetic Control Arm to Estimate Treatment Effect in Ovarian Cancer Trial GlobeNewswire
Apr-05-22 06:15AM	CLSN: DSMB Recommends Continuing to Dose Patients in OVATION 2 Study Zacks Small Cap Research +26.42%
Apr-01-22 08:00AM	Celsion Corporation Reported Cash Position of $56.9 million at December 31, 2021 GlobeNewswire
Mar-31-22 08:30AM	Celsion Corporation Reports 2021 Financial Results and Provides Business Update GlobeNewswire
Mar-24-22 09:00AM	Celsion Corporation to Hold Year-End 2021 Financial Results and Business Update Conference Call on Thursday, March 31, 2022 GlobeNewswire
Feb-28-22 09:00AM	Celsion Receives $1.4 Million from Sale of its New Jersey State Net Operating Losses GlobeNewswire -13.73%
08:30AM	Celsion Corporation Announces Stock Consolidation GlobeNewswire
Feb-17-22 08:30AM	Celsion Reports Data Safety Monitoring Board Unanimous Recommendation to Continue Dosing Patients in the Phase II Portion of the OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer GlobeNewswire
Jan-31-22 08:00AM	Celsion Corporation Advances Proof of Concept to Non-human Primate Challenge Study Against SARS-CoV-2 with In-Process Vaccine Candidate GlobeNewswire +18.10%
Jan-13-22 05:30PM	Celsion Corporation Announces Pricing of $30 Million Registered Direct Offerings of Convertible Redeemable Preferred Stock GlobeNewswire -9.62%
Jan-10-22 08:45PM	Celsion Corporation Announces Pricing of $30 Million Registered Direct Offerings of Convertible Redeemable Preferred Stock GlobeNewswire
Nov-29-21 08:30AM	Celsion Corporation Invited to Present Poster at Cytokine-Based Cancer Immunotherapies Summit GlobeNewswire +6.93%
Nov-17-21 07:25AM	CLSN: OVATION 2 Trial Nears 70% of Target Enrollment Zacks Small Cap Research
Nov-15-21 08:30AM	Celsion Corporation Reports Third Quarter 2021 Financial Results and Provides Business Update GlobeNewswire
Nov-09-21 09:00AM	Celsion Corporation to Hold Third Quarter 2021 Financial Results and Business Update Conference Call on Monday, November 15, 2021 GlobeNewswire
Nov-08-21 09:00AM	Celsion Provides Update on its Application to Sell $1.5 Million of New Jersey Net Operating Losses GlobeNewswire
08:30AM	Celsion Corporations GEN-1 IL-12 Program to be Featured at Cytokine-Based Cancer Immunotherapies Summit GlobeNewswire
Oct-15-21 09:00AM	Celsion Corporation Announces Time of Oral Presentation at International Vaccines Congress GlobeNewswire
Oct-12-21 09:00AM	Celsion Corporation Announces Oral Presentation at International Vaccines Congress GlobeNewswire
Oct-11-21 09:00AM	Celsion GmbH Announces the Publication of an Article Reviewing the History of ThermoDox® Drug Development in Advanced Drug Delivery Reviews GlobeNewswire +5.04%
08:09AM	3 Penny Stocks Insiders Are Buying Benzinga
06:44AM	CLSN: Initiating Coverage of Celsion Corporation; Novel DNA-Based Cancer Immunotherapy Technology Zacks Small Cap Research
Oct-05-21 09:00AM	Celsion Corporation Adds Key Resources to its Vaccine Development Initiative and Clinical Trial Capabilities GlobeNewswire
Sep-30-21 09:00AM	Celsion to Present at Three Investment Conferences in October GlobeNewswire
Sep-17-21 09:00AM	Celsion and Hainan Poly Pharm Sign Agreement to Manufacture Celsions DNA-based Vaccine GlobeNewswire
Sep-03-21 12:40PM	Celsion (CLSN) COVID Vaccine Effective in Pre-Clinical Studies Zacks
Sep-02-21 10:02AM	Celsion's Vaccine Platform Shows Potential Against COVID-19 In Preclinical Studies Benzinga
08:00AM	Celsion Reports T-cell and B-cell Response from In Vivo Studies with its PLACCINE DNA Vaccine Platform GlobeNewswire
Aug-14-21 05:02AM	Is Celsion (NASDAQ:CLSN) Using Debt In A Risky Way? Simply Wall St.
Aug-12-21 08:00AM	Celsion Corporation Reports Second Quarter 2021 Financial Results and Provides Business Update GlobeNewswire
Aug-05-21 08:00AM	Celsion Corporation to Hold Second Quarter 2021 Financial Results and Business Update Conference Call on Thursday, August 12, 2021 GlobeNewswire
Jul-29-21 10:00AM	Results of Celsions OVATION 1 Study with GEN-1 in Patients with Advanced Ovarian Cancer Published in the Journal of Clinical Cancer Research GlobeNewswire +10.38%
Jul-19-21 08:00AM	Celsion Reports Data Safety Monitoring Board Recommendation to Continue Dosing Patients in the Phase II Portion of the OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer GlobeNewswire +6.67%
Jul-15-21 08:00AM	Celsion Corporation Expands Vaccine Advisory Board with the Addition of Dr. Dan H. Barouch and Dr. Luke D. Handke GlobeNewswire
Jul-14-21 09:11AM	15 Best Penny Stocks to Buy Now Insider Monkey
Jul-01-21 08:00AM	Celsion GmbH Announces Commencement of Enrollment in Oxford Universitys Phase 1 Study with ThermoDox® and Focused Ultrasound in Pancreatic Cancer GlobeNewswire
Jun-23-21 08:00AM	Celsion Corporation Establishes Wholly Owned Subsidiary to Manage Investigator-Sponsored Development of ThermoDox® GlobeNewswire
Jun-21-21 08:00AM	Celsion Corporation Enters into $10 Million Strategic Loan Facility with Silicon Valley Bank GlobeNewswire
Jun-11-21 08:30AM	Do Options Traders Know Something About Celsion (CLSN) Stock We Don't? Zacks +18.46%
Jun-09-21 08:00AM	Celsion Appoints Christine A. Pellizzari to its Board of Directors GlobeNewswire
Jun-08-21 08:00AM	Celsion Corporation Appoints Dr. Stacy R. Lindborg to its Board of Directors GlobeNewswire
Jun-07-21 05:00PM	CELSION CORPORATION ANNOUNCES ADJOURNMENT OF ANNUAL MEETING GlobeNewswire
Jun-04-21 10:11AM	CELSION CORPORATION ANNOUNCES ADJOURNMENT OF ANNUAL MEETING GlobeNewswire +6.90%
Jun-02-21 08:00AM	Celsion Corporation Urges All Shareholders to Vote at the 2021 Annual Meeting to be Held on Friday June 4, 2021 GlobeNewswire
May-27-21 08:30AM	Celsion Corporation Urges All Shareholders to Vote at the 2021 Annual Meeting to be Held on Friday June 4, 2021 GlobeNewswire
May-14-21 08:15AM	Celsion Corp. to Host Earnings Call ACCESSWIRE +5.05%
08:00AM	Celsion Corporation Reports First Quarter 2021 Financial Results and Provides Business Update GlobeNewswire
May-11-21 08:00AM	Celsion Receives $1.85 Million from the Sale of its New Jersey State Net Operating Losses GlobeNewswire
May-07-21 08:30AM	Celsion Corporation to Hold First Quarter 2021 Financial Results and Business Update Conference Call on Friday, May 14, 2021 GlobeNewswire
Apr-22-21 08:30AM	Celsion Management Participates in Alliance Global Partners Virtual Series GlobeNewswire
Apr-05-21 05:00PM	CELSION CORPORATION ANNOUNCES CLOSING OF $15 MILLION REGISTERED DIRECT OFFERING GlobeNewswire
Apr-01-21 09:23AM	Celsion's Ovarian Cancer Immunotherapy Shows 41% Improvement In R0 Resection Rates Benzinga +5.80%
08:30AM	Poster on Celsion Corporations Phase I/II OVATION 2 Study Presented at the Society of Gynecologic Oncology Virtual Annual Meeting on Womens Cancer GlobeNewswire
Mar-31-21 08:00AM	CELSION CORPORATION ANNOUNCES $15 MILLION REGISTERED DIRECT OFFERING GlobeNewswire -15.34%
Mar-19-21 09:15AM	Celsion Corp. to Host Earnings Call ACCESSWIRE
08:45AM	Celsion Corporation Reports 2020 Financial Results and Provides Business Update GlobeNewswire
Mar-12-21 08:45AM	Celsion Corporation to Hold Year-End 2020 Financial Results and Business Update Conference Call on Friday, March 19, 2021 GlobeNewswire +6.22%
Mar-05-21 12:00PM	NeoPhotonics to Host Call to Discuss Optical Communications Trends and Technologies on March 10, 2021 Business Wire -7.57%
08:32AM	Do Options Traders Know Something About Celsion (CLSN) Stock We Don't? Zacks
Mar-02-21 08:45AM	Poster on Celsion Corporations Phase I/II OVATION 2 Study to be Presented at the Society of Gynecologic Oncology Virtual Annual Meeting on Womens Cancer GlobeNewswire
Mar-01-21 12:46PM	The IGO (ASX:IGO) Share Price Has Gained 110%, So Why Not Pay It Some Attention? Simply Wall St.
Feb-26-21 08:45AM	Celsion Corporation to Participate in the Virtual 33 Annual Roth Conference GlobeNewswire -6.36%
Feb-25-21 07:26PM	Is Celsion Stock a Buy Right Now? This Is What You Need to Know TipRanks
05:00PM	NeoPhotonics 400G ZR Modules Support Extended Operation up to 80C Case Temperatures Business Wire
04:10PM	NeoPhotonics Reports Fourth Quarter and Fiscal Year 2020 Financial Results Business Wire
02:45PM	NeoPhotonics Corp. to Host Earnings Call ACCESSWIRE
11:34AM	Celsion's Ovarian Cancer Immunotherapy Shows 38% Improvement In R0 Resection Rates Versus Control Arm Benzinga
08:45AM	Celsion Corporation Provides Clinical Update on Phase I/II OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer Including Encouraging Interim Resection Scores GlobeNewswire
Feb-23-21 08:00AM	Celsion Receives $2 Million Allocation Through the New Jersey Technology Business Tax Certificate Transfer (NOL) Program GlobeNewswire -15.30%
Feb-22-21 07:30AM	Celsion Corporation Receives FDA Fast Track Designation for GEN-1 in Advanced Ovarian Cancer GlobeNewswire +47.89%
05:17AM	Celsion Surges as FDA Fast-Tracks Ovarian-Cancer Drug TheStreet.com
Feb-12-21 08:30AM	Celsion Corporation Announces Formation of Vaccine Advisory Board GlobeNewswire +6.99%
03:43AM	Could The NeoPhotonics Corporation (NYSE:NPTN) Ownership Structure Tell Us Something Useful? Simply Wall St.
Feb-11-21 08:30AM	Celsion Corporation Issues Letter to Stockholders GlobeNewswire +17.44%
Feb-09-21 08:00AM	NeoPhotonics to Host Conference Call to Discuss 2020 Fourth Quarter and Year End Financial Results on Thursday, February 25, 2021 Business Wire
Feb-06-21 05:16PM	10 Best 5G Stocks to Buy Under $10 Insider Monkey
Jan-29-21 08:32AM	Is the Options Market Predicting a Spike in Celsion (CLSN) Stock? Zacks
Jan-28-21 08:00AM	Celsion Corporation Files Provisional U.S. Patent Application for a Broad Range of Next Generation DNA Vaccines GlobeNewswire
Jan-26-21 05:00PM	CELSION CORPORATION ANNOUNCES CLOSING OF $35 MILLION REGISTERED DIRECT OFFERING OF COMMON STOCK PRICED AT-THE-MARKET UNDER NASDAQ RULES GlobeNewswire +27.14%
Jan-22-21 08:40AM	CELSION CORPORATION ANNOUNCES $35 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES GlobeNewswire -21.26%
Jan-21-21 11:53PM	Celsion (NASDAQ:CLSN) Has Debt But No Earnings; Should You Worry? Simply Wall St. +36.47%
10:01AM	Looking Into Celsion's Return On Capital Employed Benzinga
08:47AM	Celsion stock rockets on heavy volume again; share sale agreement with LPC was terminated MarketWatch
Dec-29-20 01:20PM	FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Celsion Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
10:30AM	CLSN Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Celsion Corporation Shareholders With Losses Exceeding $150K of Class Action and Lead Plaintiff Deadline: December 28, 2020 ACCESSWIRE
09:37AM	DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Celsion Corporation and Encourages Investors with Losses to Contact the Firm Business Wire
09:10AM	FINAL CLSN DEADLINE TODAY: ROSEN, RESPECTED INVESTOR COUNSEL, Reminds Celsion Corporation Investors of Important Tuesday Deadline in Securities Class Action CLSN GlobeNewswire
Dec-28-20 12:55PM	DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Celsion Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm PR Newswire
09:24AM	CLSN Final Deadline Tomorrow: Rosen, Top Ranked National Investor Attorneys, Reminds Celsion Corporation Investors of Important December 29 Deadline in Securities Class Action - CLSN Newsfile
Dec-26-20 09:00AM	DEC. 29 DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Celsion Corporation CLSN GlobeNewswire
Dec-24-20 05:02PM	ROSEN, A TOP RANKED FIRM, Reminds Celsion Corporation Investors of Important Tuesday Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - CLSN Newsfile

Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Tardugno Michael H	Chairman, President and CEO	Apr 12	Buy	3.53	4,000	14,129	16,513	Apr 12 02:19 PM
Fritz Frederick J.	Director	Apr 08	Buy	4.05	5,000	20,250	11,766	Apr 11 03:09 PM
Fritz Frederick J.	Director	Mar 02	Buy	4.69	2,000	9,372	6,766	Mar 03 12:49 PM
Fritz Frederick J.	Director	Oct 07	Buy	0.88	20,000	17,600	71,491	Oct 08 08:50 AM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience